Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Apr 24;105(1):136–147. doi: 10.3324/haematol.2018.212365

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright© 2020 Ferrata Storti Foundation

Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions:

https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions:

https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher.

PMC Copyright notice

Figure 5. — Expression of CD44 is influenced by BCR-ABL1. (A) Median fluorescence intensity (MFI) of CD44 on BaF3 cells transduced with empty vector or BCR-ABL1 plated on E-selectin after treatment with vehicle or 10 mM imatinib [P values as indicated, analysis of variance (ANOVA); Tukey test, n=3]. (B) MFI of CD44 (fold change) on the non-adherent and adherent fractions of BCR-ABL1⁺ BaF3 cells after treatment with vehicle, GMI-1271, imatinib or GMI-1271 and imatinib, normalized to vehicle (P=0.005 for vehicle vs. GMI-1271 plus imatinib, ANOVA; Tukey test, n=4).